Mobiles can help you better manage your medications

By Candy Gibson

Nurse managing medications on a smartphone

A UniSA PhD researcher is testing whether smartphone text messages can encourage cancer patients to take their oral medication and improve their chances of survival.

The program, developed by Mara Skrabal Ross, hopes to address the poor adherence rates among cancer patients. Currently, fewer than half (46 per cent) adhere to their prescribed oral medication, sometimes leading to fatal consequences. 

In adolescents and young adults, this figure is as low as 16 per cent. 

Skrabal Ross says mobile phones are increasingly being used to help a range of chronically ill patients stick to their treatment regimes, with SMS (text messages) the most common tool for people with diabetes, HIV, heart disease and high blood pressure. Mobile phone applications are also delivering information to patients, collecting real-time data and generating specific reports on a patient’s condition. 

“In Australia, 85 per cent of the population own a mobile phone, as do 67 per cent worldwide. Smartphones have successfully been used to improve medication adherence for a range of chronic illnesses, but research into their ability to support regular oral chemotherapy intake is lacking,” Skrabal Ross says. 

Cancer patients prescribed oral chemotherapy, aged between 16 to 75 years, are being sought for the 10-week study which will inform a larger clinical trial. 

Skrabal Ross says a quarter of drugs approved for cancer are now administered orally, posing new challenges for patients and caregivers who often feel overwhelmed by their cancer diagnosis and the need to manage their treatment outside of a hospital setting. 

“It’s crucial to strictly adhere to the oral medication prescribed to ensure patients are giving themselves the best chance of beating cancer. Most oncology practices are not equipped to monitor patients taking oral chemotherapy, so smartphone technology could be the answer.” 

Anyone seeking more information can contact Mara Skrabal Ross by email at